Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.
about
Antibodies directed against rubella virus induce demyelination in aggregating rat brain cell culturesHuman nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous systemAmelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by photobiomodulation induced by 670 nm lightNeurobehavioral development of common marmoset monkeys.Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelinationMyelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases.Therapeutic strategies in multiple sclerosis. I. ImmunotherapySurprising pleiotropy of nerve growth factor in the treatment of experimental autoimmune encephalomyelitis.T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis.Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis.Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis.Elevated intrathecal myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis.Limited sufficiency of antigen presentation by dendritic cells in models of central nervous system autoimmunity.Preclinical assessment of stem cell therapies for neurological diseases.Effects of early IL-17A neutralization on disease induction in a primate model of experimental autoimmune encephalomyelitis.Gene therapy in nonhuman primate models of human autoimmune disease.Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice.Update on the autoimmune pathology of multiple sclerosis: B-cells as disease-drivers and therapeutic targetsIdentification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis.T cell subsets and their signature cytokines in autoimmune and inflammatory diseases.B cell antigen presentation is sufficient to drive neuroinflammation in an animal model of multiple sclerosis.B cells in multiple sclerosis.Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy.Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis.Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein.B cells and autoantibodies in the pathogenesis of multiple sclerosis and related inflammatory demyelinating diseasesAutoantigen conformation influences both B- and T-cell responses and encephalitogenicityThe Charcot Lecture | beating MS: a story of B cells, with twists and turnsSelf-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein.IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitisTreatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and up-regulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis.Antigen-specific therapies in multiple sclerosis: going beyond proteins and peptides.A critical role for lymphotoxin in experimental allergic encephalomyelitis.Critical role of activation induced cytidine deaminase in experimental autoimmune encephalomyelitis.Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis.B cells limit epitope spreading and reduce severity of EAE induced with PLP peptide in BALB/c miceSystems biology approaches for the study of multiple sclerosis.Identification of gene expression patterns crucially involved in experimental autoimmune encephalomyelitis and multiple sclerosis.MHC haplotype-dependent regulation of MOG-induced EAE in rats.MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies.
P2860
Q24290584-056873BD-7C7C-4151-81D0-F65D3FEFE1B9Q28144436-9872D728-DB89-42BB-B1A3-3419270ADEE9Q28732434-B3FC38F0-8120-477F-83F3-8EBCF2899985Q30375150-8124E10C-88AA-48E7-8C72-418AF5DF8457Q31076579-675DBA60-A80A-445D-A1C7-6C995386DD51Q33645795-74A01353-43B3-43A5-8A2D-E63D8A0BBCC9Q33798254-C3AF7946-F6F9-40B8-9C47-76E501790F46Q33919193-BBCB09F4-22D2-41D1-94F1-617040E50E3CQ34398673-B5D1A162-D350-45E7-B767-7CE573DCFEEFQ34431835-5D55A1F2-0C37-453B-8FDF-4D0E15D9B39EQ34479121-F54A5524-D9FF-4097-89B3-EC5C5E1A631AQ34636372-998CE925-0FF5-4C3F-AAE5-B42477084699Q34645411-90989CBC-2548-412A-A75B-59EC28377F68Q34786764-EE21E917-9225-4233-90E4-8044750BAE7FQ35082644-E28557FB-E1F5-4FA9-9140-B7428301A98BQ35122173-BD319F4B-58D0-4C64-9B72-C31BE9FBCF9CQ35242814-3C4591CC-29DF-42D7-9D59-EED154E9CAF8Q35463552-78DC74BF-D7F9-4FF3-A7B0-D418710C4BE0Q35539775-7D3802A7-4C60-4503-8C72-E05B8A4FFD5AQ35558638-CC96090E-1D65-4322-9188-0575B192816DQ35613006-CC2AB292-B2A4-43B6-8372-675080061625Q35650942-B26D4BE8-4A94-44DA-AA4E-8D7380E1654AQ35753349-8CF37945-0B5B-48B3-88B0-43378AF03B2EQ35805634-B5EE2827-9046-4AD3-B266-EF878529635CQ35891689-86DB4BC2-E6AD-4454-BEB3-CCC47A3562C6Q35903957-887C2112-51C3-41E8-A7A7-4CE93F2D5168Q36007039-F2F0CD2B-A0F7-4105-B445-900390B18799Q36086475-2F4D0A5D-CBC9-4568-B280-9F72F3C9DBD5Q36194449-961C4C23-6188-4CB6-B075-3D7E52ED702AQ36281698-F372C2EC-5E17-4AFF-B9F2-2851D376DAE1Q36299378-573F6EF7-9982-4CF5-9E1C-70C94EA8A6FDQ36327377-E7F98944-DE98-4D8E-AFD5-5DE5F9202D57Q36380767-F2C2BE07-FEE9-4E09-BE4C-A8598DA25AF1Q36634895-E80EF87F-E59D-4326-B4D6-0EB62DBADFF1Q36803471-CE941E0D-6F6C-4017-A301-8ED37423B627Q36967223-A53AFEAD-2E4D-4587-8143-19BEE9735B89Q37174203-04D0BEF2-EA75-4523-8CAE-4F4FBB102599Q37381605-3DE5511F-1FC3-4FBE-93CE-3FC9C648BD43Q37387696-7ACA641A-9727-48A2-9686-1CBAA16F81F7Q37397820-3CD27C91-C6D7-4FDE-A04E-B3FE7479D34F
P2860
Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.
@ast
Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.
@en
type
label
Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.
@ast
Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.
@en
prefLabel
Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.
@ast
Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.
@en
P2093
P2860
P356
P1476
Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate
@en
P2093
C P Genain
M H Nguyen
N L Letvin
S L Hauser
P2860
P304
P356
10.1172/JCI118368
P407
P577
1995-12-01T00:00:00Z